Total Funding
65
66
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
67755
MultiplexDX is a biotechnology research firm that focuses on development of the technologies and products for molecular diagnostic markets.
- Pavol Cekan: CEO and Co-founder
- Peter Kilian: Chief Operating Officer
About the Company
MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology and
histopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.
MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.
